Neonatal Abstinence Syndrome (NAS): Causes, Effects and Treatment
*Corresponding Author: Garcia Thomas, Department of neuroscience, Yale University, United States, Email: thomas394@gmail.comReceived Date: Dec 01, 2024 / Published Date: Dec 29, 2024
Citation: Garcia T (2024) Neonatal Abstinence Syndrome (NAS): Causes, Effects and Treatment. Clin Neuropsycho, 7: 267.DOI: 10.4172/cnoa.1000266
Copyright: © 2024 Garcia T. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited


Abstract
Neonatal Abstinence Syndrome (NAS) is a condition in which newborns experience withdrawal symptoms due to prenatal exposure to drugs, particularly opioids. NAS has become a growing public health concern, driven by the increasing rates of opioid use and misuse among pregnant women. When a fetus is exposed to opioids or other substances, it becomes dependent on the drug. After birth, the sudden withdrawal from the drug leads to a variety of symptoms that can include irritability, tremors, feeding difficulties, vomiting, diarrhea, and respiratory distress. In severe cases, NAS can cause seizures and long-term developmental delays. The primary cause of NAS is maternal drug use during pregnancy, with opioids such as heroin, prescription painkillers, and methadone being the most common substances involved. However, other substances, including alcohol, tobacco, and benzodiazepines, can also contribute to NAS. Polydrug use, where mothers consume multiple substances simultaneously, further complicates the condition and may exacerbate symptoms.